EZEl Zaher Hassan El Zaher

El Zaher Hassan El Zaher

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


El Zaher Hassan El Zaher has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synovial Fluid White Blood Cell Count as a Potential Biomarker for the Clinical Severity of Knee Osteoarthritis: A Prospective Study

    by Hesham El-Khodary, Ahmed Nageeb Mahmoud, Daniel S. Horwitz, Elzaher Hassan Elzaher, Mostafa Aly Elabd, Mariia Sovalkina, Ahmed Samy Kamel, Ahmed Mohasseb

    Knee osteoarthritis is categorized classically as a non-inflammatory arthropathy. However, there has been increasing evidence regarding the supplementary role of inflammation in the pathogenesis and disease progression of knee osteoarthritis. This study aims to identify a potential correlation between synovial fluid white blood cell (SF WBC) count and the severity of knee osteoarthritis clinical presentation. 200 knees (200 patients) were assessed through SF aspiration and cytology analysis for WBC count. All patients have filled out the Knee Injury and Osteoarthritis Outcome Score for clinical correlation. For the 200 knees, there was a statistically significant positive correlation between the severity of osteoarthritis clinical presentation as expressed by the Knee Injury and Osteoarthritis Outcomes Score (KOOS) and the synovial white blood cell count among the studied cases (p-value < 0.001). There was no statistically significant correlation found between the patient's age, sex, or side and KOOS or SF white cell count. The clinical severity of knee osteoarthritis is directly correlated with increased SF white cell count, and hence, SF WBCs may play a role in identifying and grading osteoarthritis clinical severity. This may raise the interest in identifying the role of using specific disease-modifying drugs that deal with the WBC function in cases of osteoarthritis along with other modalities. Received: 30 April 2024 | Revised: 22 July 2024 | Accepted: 12 September 2024 Conflicts of Interest The authors declare that they have no conflicts of interest to this work. Data Availability Statement The data that support this work are available upon reasonable request to the corresponding author. Author Contribution Statement Hesham El-khodary: Conceptualization, Methodology, Software, Validation, Formal analysis, Investigation, Resources, Data curation. Ahmed Nageeb Mahmoud: Software, Writing - original draft, Writing - review & editing, Visualization. Daniel S. Horwitz: Writing - review & editing, Visualization. Elzaher Hassan Elzaher: Resources, Writing - review & editing, Visualization. Mostafa Aly Elabd: Software, Resources, Writing - review & editing. Mariia Sovalkina: Software, Formal analysis. Ahmed Samy Kamel: Conceptualization, Methodology, Investigation, Resources, Data curation, Supervision, Project administration. Ahmed Mohasseb: Conceptualization, Methodology, Validation, Formal analysis, Investigation, Resources, Data curation, Supervision, Project administration.


  • Open Access

    Study the Results of Antibiotic Prophylactic Protocol Adopted by Ain Shams University Hospitals for reducing the Risk of Surgical Site Infection in Patients undergoing Hip Arthroplasty, Pilot Study

    by El Zaher Hassan El Zaher, Shady Samir, Ahmed Mohamed Khaled, Ahmed Mohamed Abdel Rahman Mohamed Farrage

    Background: Total hip arthroplasties are well-proven solutions in case of end-stage osteoarthritis of the hip joint. Although, presence of complications can be devastating for the patient, especially periprosthetic joint infection (PJI). To prevent PJI, antibiotic prophylaxis regimens are regularly used. Objectives: To study the association of antibiotic choice, duration and dosage with prevalence of surgical site infection among patients with hip arthroplasty and identify risk factors for surgical site infection in patient with hip arthroplasty. Patients and Methods: After obtaining the hospitals Research/Ethics Committee approval and written informed consents from the patients, this study was carried on. 30 patients with primary hip arthroplasty surgery and all operations were performed by senior staff members. All patients were screened for suitability by detailed clinical assessment of their history and physical examination as well as radiological investigations. Results: The result of this study was that we have 2 cases infected from 30 cases with percent of infection among patient with primary hip arthroplasty is 6.7% and by studying the risk factors for infection there was no specific risk factor for infection except for patient with cardiac disease have increased risk of infection. Conclusion: In conclusion, this study postulated that systemic antibiotic prophylaxis delivered preoperatively in primary THA procedures significantly reduces the incidence of infection. There is no significant difference in the efficacy of cephalosporins compared with that of quinolones. Prophylactic antibiotics should be taken IV before skin incision by 30-60 minutes and no need for antibiotics more than 24 hours after operation.